| Oct 19 |
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
|
| Oct 19 |
Johnson & Johnson: Q3 Earnings Highlights Resilience And New Growth
|
| Oct 18 |
Johnson & Johnson (JNJ): Growth Prospects Enhanced by Key Acquisitions and Approvals
|
| Oct 18 |
Pharma Stock Roundup: JNJ's Q3 Earnings, FDA Nod to Some New Drugs
|
| Oct 18 |
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
|
| Oct 18 |
Boston Scientific stock down as Needham cuts to Hold on growth concerns
|
| Oct 18 |
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
|
| Oct 17 |
Johnson & Johnson Stock: Setting the Stage for 2025 Highs
|
| Oct 17 |
Johnson & Johnson Q3 Earnings Review: Nicely Poised For Steady Growth (Upgrade)
|
| Oct 17 |
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike
|
